Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You are browsing as a GUEST
Title of the item:

Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study)

Title :
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study)
Authors :
Yamashita, Toshinari
Kawaguchi, Hidetoshi
Masuda, Norikazu
Kitada, Masahiro
Narui, Kazutaka
Hattori, Masaya
Yoshinami, Tetsuhiro
Matsunami, Nobuki
Yanagihara, Kazuhiro
Kawasoe, Teru
Nagashima, Takeshi
Bando, Hiroko
Yano, Hiroshi
Hasegawa, Yoshie
Nakamura, Rikiya
Kashiwaba, Masahiro
Morita, Satoshi
Ohno, Shinji
Toi, Masakazu
Show more
Source :
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 39(1):217-225
Academic Journal

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.